» Articles » PMID: 15096610

Human Claspin Works with BRCA1 to Both Positively and Negatively Regulate Cell Proliferation

Overview
Specialty Science
Date 2004 Apr 21
PMID 15096610
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Claspin is a homolog of Mrc1, a checkpoint protein required for the DNA replication checkpoint in yeast. In Xenopus, phosphorylated Claspin binds to xChk1 and regulates xChk1 activation in response to replication stress. In this study, we have shown that the human homolog of Claspin is required for resistance to multiple forms of genotoxic stress including UV, IR, and hydroxyurea. Phosphorylation of Claspin was found to depend on the ataxia telangiectasia mutated-Rad3 related (ATR) pathway. DNA damage induces the formation of a complex between Claspin and BRCA1, a second regulator of Chk1 activation. Claspin was found to control BRCA1 phosphorylation on serine 1524, a site whose phosphorylation is controlled by the ATR pathway. These results are consistent with a model in which ATR regulates Claspin phosphorylation in response to DNA damage and replication stress resulting in recruitment and phosphorylation of BRCA1. BRCA1 and Claspin then function to activate the tumor suppressor Chk1. Unexpectedly, we found that Claspin has a second, positive role in control of the cell cycle as Claspin overexpression increased cell proliferation. These results suggest that Claspin has properties of both a tumor suppressor and an oncogene.

Citing Articles

Targeting the Cdc2-like kinase 2 for overcoming platinum resistance in ovarian cancer.

Jiang Y, Huang S, Zhang L, Zhou Y, Zhang W, Wan T MedComm (2020). 2024; 5(4):e537.

PMID: 38617434 PMC: 11016135. DOI: 10.1002/mco2.537.


The Adaptive Mechanisms and Checkpoint Responses to a Stressed DNA Replication Fork.

Saldanha J, Rageul J, Patel J, Kim H Int J Mol Sci. 2023; 24(13).

PMID: 37445667 PMC: 10341514. DOI: 10.3390/ijms241310488.


A multi-omics analysis reveals CLSPN is associated with prognosis, immune microenvironment and drug resistance in cancers.

Chen Y, Wen H, Li Y, Han Y, Tan J, Guo C Biol Proced Online. 2023; 25(1):16.

PMID: 37268895 PMC: 10239117. DOI: 10.1186/s12575-023-00201-6.


The TIMELESS effort for timely DNA replication and protection.

Patel J, Kim H Cell Mol Life Sci. 2023; 80(4):84.

PMID: 36892674 PMC: 9998586. DOI: 10.1007/s00018-023-04738-3.


Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model.

Suominen M, Knuuttila M, Schatz C, Schlicker A, Vaaraniemi J, Sjoholm B Int J Mol Sci. 2023; 24(3).

PMID: 36768509 PMC: 9916479. DOI: 10.3390/ijms24032189.


References
1.
Osborn A, Elledge S . Mrc1 is a replication fork component whose phosphorylation in response to DNA replication stress activates Rad53. Genes Dev. 2003; 17(14):1755-67. PMC: 196183. DOI: 10.1101/gad.1098303. View

2.
Yarden R, Pardo-Reoyo S, Sgagias M, Cowan K, Brody L . BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat Genet. 2002; 30(3):285-9. DOI: 10.1038/ng837. View

3.
Chini C, Chen J . Human claspin is required for replication checkpoint control. J Biol Chem. 2003; 278(32):30057-62. DOI: 10.1074/jbc.M301136200. View

4.
Katou Y, Kanoh Y, Bando M, Noguchi H, Tanaka H, Ashikari T . S-phase checkpoint proteins Tof1 and Mrc1 form a stable replication-pausing complex. Nature. 2003; 424(6952):1078-83. DOI: 10.1038/nature01900. View

5.
Liu Q, Guntuku S, Cui X, Matsuoka S, Cortez D, Tamai K . Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev. 2000; 14(12):1448-59. PMC: 316686. View